Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2022-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/3/e001931corr2.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
by: Dirk Schadendorf, et al.
Published: (2021-01-01) -
The impact of immune checkpoint inhibition on atherosclerosis in cancer patients
by: Rui Han, et al.
Published: (2025-07-01) -
Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors
Published: (2023-04-01) -
Correction: Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Published: (2025-03-01) -
Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity
by: Martina Schniederova, et al.
Published: (2025-01-01)